FDA Warning Letter An FDA warning letter is a serious regulatory communication that identifies significant violations of FDA requirements and allows a pharmaceutical manufacturer to take corrective action. In this case, the FDA warning letter identifies three major CGMP deficiencies related to finished-product testing, incoming material controls, and cleaning validation. These findings demonstrate the importance … Read more
CAPA Effectiveness in the Pharma Industry Repeated Environmental Monitoring Excursions Scenario: During routine environmental monitoring of a Grade C manufacturing area, repeated excursions in microbial counts are observed at a specific monitoring location. Initial Observation – Over three months: Multiple microbial excursions occurred at the same location. Initial investigations focused primarily on cleaning and operator practices. … Read more
Continual Improvement of the Pharmaceutical Quality System: A Practical FDA, ICH & PIC/S Framework A pharmaceutical quality system should do more than demonstrate compliance. It should enable an organization to identify emerging risks, understand process performance, learn from quality events, and continuously improve its operations. For pharmaceutical manufacturers supplying the United States, continual improvement should … Read more